# SERPINB9

## Overview
SERPINB9 is a gene that encodes the protein serpin family B member 9, also known as Proteinase Inhibitor 9 (PI-9). This protein is a member of the serpin superfamily, which is characterized by its role as a serine protease inhibitor. Serpin B9 is primarily involved in inhibiting granzyme B, a serine protease that plays a critical role in inducing apoptosis in target cells. This inhibition is crucial for protecting immune cells, such as cytotoxic T lymphocytes and natural killer cells, from self-inflicted damage during immune responses (Wang2021Overview; Huang2024The). The protein is expressed in various immune-privileged sites and is involved in modulating immune responses, influencing cytokine production, and participating in antigen presentation (Reinstein2022Presence; Huang2024The). Dysregulation of SERPINB9 expression is associated with several pathological conditions, including cancer, where it contributes to immune evasion and treatment resistance, as well as autoimmune and inflammatory diseases (Wang2021Overview; Huang2024The).

## Structure
Serpin B9, also known as PI-9, is a single-chain protein composed of 376 amino acids with a molecular weight of approximately 42 kDa (Wang2021Overview; Huang2024The). The protein is characterized by a conserved tertiary structure typical of the serpin superfamily, which includes nine α-helices and three β-sheets (Wang2021Overview; Kaiserman2009Control). A key feature of Serpin B9 is its reactive center loop (RCL), which contains 17 amino acids and is crucial for its inhibitory function. This loop is located near the C-terminus and plays a significant role in the protein's interaction with target proteases (Wang2021Overview; Huang2024The).

The RCL of Serpin B9 includes a specific PI-PI' site with a highly conserved cysteine pair, which determines the specificity of protease inhibition (Wang2021Overview). The protein inhibits granzyme B by forming a reversible Michaelis complex, followed by a covalent complex through an ester linkage (Huang2024The). Serpin B9 does not have a quaternary structure as it functions as a monomeric protein. There is no detailed information on post-translational modifications or splice variant isoforms in the provided context.

## Function
SERPINB9, also known as Proteinase Inhibitor 9 (PI-9), is a crucial intracellular serpin that primarily functions to inhibit granzyme B (GzmB), a serine protease involved in inducing apoptosis in target cells. This inhibition is vital for protecting cells, particularly immune cells such as cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells, from self-inflicted damage during immune responses (Wang2021Overview; Huang2024The). SERPINB9 achieves this by forming a reversible Michaelis complex with GzmB, followed by a covalent complex, effectively neutralizing its apoptotic activity (Huang2024The).

In healthy human cells, SERPINB9 is extensively expressed in immune-privileged sites, including the placenta, testes, ovaries, and eyes, as well as in cytotoxic lymphocytes and antigen-presenting cells (Reinstein2022Presence; Huang2024The). It plays a role in regulating immune responses by modulating inflammatory caspases and influencing cytokine production, thereby maintaining immune homeostasis and preventing inappropriate apoptosis (Huang2024The). SERPINB9 is also involved in antigen presentation and cross-presentation by dendritic cells, contributing to immune regulation and potentially affecting immune surveillance and response (Huang2024The). Its expression is associated with various physiological and pathological processes, including immune evasion in tumors and protection against cytotoxic lymphocyte attacks in transplantation models (Huang2024The).

## Clinical Significance
Alterations in the expression of the SERPINB9 gene, also known as PI-9, have significant clinical implications in various diseases. In cancer, overexpression of SERPINB9 is linked to immune evasion and treatment resistance. High levels of SERPINB9 are associated with metastasis and poor prognosis in colorectal carcinoma, breast cancer, and lung cancer (Wang2021Overview). In multiple myeloma, elevated SERPINB9 expression is observed in recurrent and relapsed cases, suggesting its role in disease progression (Chen2021ProteomicsBased). SERPINB9 also contributes to chemoresistance, as seen in rectal cancer and acute lymphoblastic leukemia, where high levels correlate with poor chemotherapy response (Wang2021Overview).

In the context of infections, SERPINB9 expression increases during viral infections, such as those caused by cytomegalovirus and Epstein-Barr virus, potentially aiding pathogen survival by protecting host cells from apoptosis (Huang2024The). In autoimmune and inflammatory diseases, the SERPINB9 A329S variant is linked to autoinflammatory conditions due to its impaired inhibition of caspase-1 and IL-1b (Huang2024The). SERPINB9's role in immune regulation and its dysregulation in various conditions highlight its potential as a therapeutic target and biomarker in cancer and other diseases (Huang2024The).

## Interactions
SERPINB9, also known as Proteinase Inhibitor 9 (PI-9), is primarily known for its interaction with granzyme B (GrB), a serine protease released by cytotoxic T lymphocytes and natural killer cells. This interaction is crucial for inhibiting GrB's proteolytic activity, thereby protecting cells from apoptosis. SERPINB9 forms a reversible Michaelis complex with GrB, which is followed by covalent complex formation, effectively neutralizing GrB's cytotoxic effects (Wang2021Overview; Huang2024The).

In addition to its interaction with GrB, SERPINB9 also influences cytokine production by modulating inflammatory caspase-1 and, to a lesser extent, caspase-4 and caspase-8. However, its interaction with caspases-8 and -10 is limited due to low association rate constants (Huang2024The). SERPINB9 also acts as an intracellular inhibitor of neutrophil elastase, protecting neutrophils from self-damage and influencing neutrophil immunity (Huang2024The).

SERPINB9's role extends to immune regulation, where it is involved in antigen presentation and cross-presentation by CD8+ dendritic cells, independently of GrB (Huang2024The). These interactions highlight SERPINB9's multifaceted role in immune response modulation and cellular protection.


## References


[1. (Huang2024The) Haozhe Huang, Yiqing Mu, and Song Li. The biological function of serpinb9 and serpinb9-based therapy. Frontiers in Immunology, June 2024. URL: http://dx.doi.org/10.3389/fimmu.2024.1422113, doi:10.3389/fimmu.2024.1422113. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2024.1422113)

[2. (Kaiserman2009Control) D Kaiserman and P I Bird. Control of granzymes by serpins. Cell Death &amp; Differentiation, 17(4):586–595, November 2009. URL: http://dx.doi.org/10.1038/cdd.2009.169, doi:10.1038/cdd.2009.169. This article has 101 citations.](https://doi.org/10.1038/cdd.2009.169)

[3. (Reinstein2022Presence) Stanislava Reinstein Merjava, Jan Kossl, Ales Neuwirth, Pavlina Skalicka, Zuzana Hlinomazova, Vladimir Holan, and Katerina Jirsova. Presence of protease inhibitor 9 and granzyme b in healthy and pathological human corneas. Biology, 11(5):793, May 2022. URL: http://dx.doi.org/10.3390/biology11050793, doi:10.3390/biology11050793. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biology11050793)

[4. (Wang2021Overview) Wen-Jun Wang, Jiao Wang, Chao Ouyang, Chong Chen, Xiao-Feng Xu, and Xiao-Qun Ye. Overview of serpin b9 and its roles in cancer (review). Oncology Reports, July 2021. URL: http://dx.doi.org/10.3892/or.2021.8141, doi:10.3892/or.2021.8141. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/or.2021.8141)

[5. (Chen2021ProteomicsBased) Yao Chen, Lina Quan, Chuiming Jia, Yiwei Guo, Xinya Wang, Yu Zhang, Yan Jin, and Aichun Liu. Proteomics-based approach reveals the involvement of serpinb9 in recurrent and relapsed multiple myeloma. Journal of Proteome Research, 20(5):2673–2686, March 2021. URL: http://dx.doi.org/10.1021/acs.jproteome.1c00007, doi:10.1021/acs.jproteome.1c00007. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/acs.jproteome.1c00007)